Unknown

Dataset Information

0

Time Course of C-Reactive Protein and Procalcitonin Levels During the Treatment of Acute Bacterial Skin Infections.

ABSTRACT: In a pilot study of 22 patients with an acute bacterial skin infection, serum levels of C-reactive protein and procalcitonin tended to be elevated at presentation and declined within 3-5 days of treatment. Further study of a biomarker-guided treatment strategy to reduce antibiotic overuse in skin infections is warranted.

SUBMITTER: Jenkins TC 

PROVIDER: S-EPMC5830966 | biostudies-literature | 2018 Mar

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Time Course of C-Reactive Protein and Procalcitonin Levels During the Treatment of Acute Bacterial Skin Infections.

Jenkins Timothy C TC   Haukoos Jason S JS   Cotton Eleanor E   Weitzenkamp David D   Frank Daniel N DN   Burman William J WJ  

Open forum infectious diseases 20180130 3

In a pilot study of 22 patients with an acute bacterial skin infection, serum levels of C-reactive protein and procalcitonin tended to be elevated at presentation and declined within 3-5 days of treatment. Further study of a biomarker-guided treatment strategy to reduce antibiotic overuse in skin infections is warranted. ...[more]

Similar Datasets

Unknown Emerging treatment options for acute bacterial skin and skin structure infections: focus on intravenous delafloxacin.
| S-EPMC5894714 | biostudies-other
Unknown Critical role of tedizolid in the treatment of acute bacterial skin and skin structure infections.
| S-EPMC5191846 | biostudies-other
Unknown Potential role of tedizolid phosphate in the treatment of acute bacterial skin infections.
| S-EPMC3622392 | biostudies-other
Unknown Combination of procalcitonin and C-reactive protein levels in the early diagnosis of bacterial co-infections in children with H1N1 influenza.
| S-EPMC6379630 | biostudies-literature
Unknown Patient preferences for treatment of acute bacterial skin and skin structure infections in the emergency department.
| S-EPMC6278032 | biostudies-literature
Unknown Profile of tedizolid phosphate and its potential in the treatment of acute bacterial skin and skin structure infections.
| S-EPMC4411017 | biostudies-other
Unknown Safety, tolerability, and efficacy of GSK1322322 in the treatment of acute bacterial skin and skin structure infections.
| S-EPMC4249383 | biostudies-literature
Unknown Delafloxacin: A Review in Acute Bacterial Skin and Skin Structure Infections.
| S-EPMC7497496 | biostudies-literature
Unknown Dexamethasone and tocilizumab treatment considerably reduces the value of C-reactive protein and procalcitonin to detect secondary bacterial infections in COVID-19 patients.
| S-EPMC8340482 | biostudies-literature
Unknown Procalcitonin Levels in Acute Respiratory Infection.
| S-EPMC4782030 | biostudies-literature